Virtu Financial LLC Xenetic Biosciences, Inc. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$0.59 - $5.57 $11,643 - $109,918	19,734 New	19,734 $11,000
Q1 2022 May 17, 2022	SELL	$0.88 - $1.37 $40,230 - $62,630	-45,716 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$1.27 - $2.08 $58,059 - $95,089	45,716 New	45,716 $59,000
Q2 2021 Sep 17, 2021	SELL	$1.57 - $2.45 $58,397 - $91,130	-37,196 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$2.01 - $3.5 $35,371 - $61,593	17,598 Added 89.79%	37,196 $81,000
Q4 2020 Feb 24, 2021	BUY	$0.79 - $3.17 $15,482 - $62,125	19,598 New	19,598 $40,000
Q4 2019 Feb 04, 2020	SELL	$1.05 - $1.66 $36,813 - $58,199	-35,060 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$1.2 - $12.7 $42,072 - $445,262	35,060 New	35,060 $42,000

Ticker XBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,166,600
Market Cap $64.6M
Description
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-base...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.